1 Market Overview

1.1 Human Immunoglobulin(pH4) for Intravenous Injection Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 1g/20ml

1.2.3 1.25g/25ml

1.2.4 2.5g/50ml

1.2.5 5g/100ml

1.2.6 10g/200ml

1.3 Market Analysis by Application

1.3.1 Overview: Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size & Forecast

1.4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Value (2016-2026))

1.4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume (2016-2026)

1.4.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2026) & (US$/Unit)

1.5 Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity Analysis

1.5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Total Production Capacity (2016-2026)

1.5.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers

1.6.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints

1.6.3 Human Immunoglobulin(pH4) for Intravenous Injection Trends Analysis

2 Manufacturers Profiles

2.1 Boya-Bio

2.1.1 Boya-Bio Details

2.1.2 Boya-Bio Major Business

2.1.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.1.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Beijing Tiantan Biological Products

2.2.1 Beijing Tiantan Biological Products Details

2.2.2 Beijing Tiantan Biological Products Major Business

2.2.3 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.2.4 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Hualan Bio

2.3.1 Hualan Bio Details

2.3.2 Hualan Bio Major Business

2.3.3 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.3.4 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Guangdong Shuagnlin Bio-pharmacy

2.4.1 Guangdong Shuagnlin Bio-pharmacy Details

2.4.2 Guangdong Shuagnlin Bio-pharmacy Major Business

2.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Weiguang Biological

2.5.1 Weiguang Biological Details

2.5.2 Weiguang Biological Major Business

2.5.3 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.5.4 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Sinopharm

2.6.1 Sinopharm Details

2.6.2 Sinopharm Major Business

2.6.3 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.6.4 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Shanghai RAAS

2.7.1 Shanghai RAAS Details

2.7.2 Shanghai RAAS Major Business

2.7.3 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.7.4 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 CTBB

2.8.1 CTBB Details

2.8.2 CTBB Major Business

2.8.3 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.8.4 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Nanyue Biopharming

2.9.1 Nanyue Biopharming Details

2.9.2 Nanyue Biopharming Major Business

2.9.3 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

2.9.4 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturer

3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Human Immunoglobulin(pH4) for Intravenous Injection

3.4 Market Concentration Rate

3.4.1 Top 3 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturer Market Share

3.4.2 Top 6 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturer Market Share

3.5 Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Human Immunoglobulin(pH4) for Intravenous Injection Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Region

4.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Region (2016-2026)

4.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2026)

4.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026)

4.3 Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026)

4.4 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026)

4.5 South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026)

4.6 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Type (2016-2026)

5.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2026)

5.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Application (2016-2026)

6.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2026)

6.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2026)

7.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2026)

7.3 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Country

7.3.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Country (2016-2026)

7.3.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2026)

8.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2026)

8.3 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Country

8.3.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Country (2016-2026)

8.3.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2026)

9.2 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2026)

9.3 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Region

9.3.1 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2026)

10.2 South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2026)

10.3 South America Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Country

10.3.1 South America Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Country (2016-2026)

10.3.2 South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2026)

11.2 Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2026)

11.3 Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Country

11.3.1 Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Human Immunoglobulin(pH4) for Intravenous Injection Typical Distributors

12.3 Human Immunoglobulin(pH4) for Intravenous Injection Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type, (USD Million), 2021-2026

Table 2. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application, (USD Million), 2021-2026

Table 3. Boya-Bio Basic Information, Manufacturing Base and Competitors

Table 4. Boya-Bio Major Business

Table 5. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 6. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors

Table 8. Beijing Tiantan Biological Products Major Business

Table 9. Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 10. Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Hualan Bio Basic Information, Manufacturing Base and Competitors

Table 12. Hualan Bio Major Business

Table 13. Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 14. Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors

Table 16. Guangdong Shuagnlin Bio-pharmacy Major Business

Table 17. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 18. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Weiguang Biological Basic Information, Manufacturing Base and Competitors

Table 20. Weiguang Biological Major Business

Table 21. Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 22. Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Sinopharm Basic Information, Manufacturing Base and Competitors

Table 24. Sinopharm Major Business

Table 25. Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 26. Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Shanghai RAAS Basic Information, Manufacturing Base and Competitors

Table 28. Shanghai RAAS Major Business

Table 29. Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 30. Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. CTBB Basic Information, Manufacturing Base and Competitors

Table 32. CTBB Major Business

Table 33. CTBB Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 34. CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors

Table 36. Nanyue Biopharming Major Business

Table 37. Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Product and Services

Table 38. Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturer (2019-2021e) & (K Units)

Table 40. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 41. Market Position of Manufacturers in Human Immunoglobulin(pH4) for Intravenous Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 42. Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity by Company, (K Units): 2020 VS 2021

Table 43. Head Office and Human Immunoglobulin(pH4) for Intravenous Injection Production Site of Key Manufacturer

Table 44. Human Immunoglobulin(pH4) for Intravenous Injection New Entrant and Capacity Expansion Plans

Table 45. Human Immunoglobulin(pH4) for Intravenous Injection Mergers & Acquisitions in the Past Five Years

Table 46. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021e) & (K Units)

Table 47. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2021-2026) & (K Units)

Table 48. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021e) & (USD Million)

Table 49. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2021-2026) & (USD Million)

Table 50. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 51. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 52. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2021e) & (USD Million)

Table 53. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2021-2026) & (USD Million)

Table 54. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2021e) & (US$/Unit)

Table 55. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2021-2026) & (US$/Unit)

Table 56. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 57. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 58. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2021e) & (USD Million)

Table 59. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2021-2026) & (USD Million)

Table 60. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021e) & (US$/Unit)

Table 61. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2021-2026) & (US$/Unit)

Table 62. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021e) & (K Units)

Table 63. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2021-2026) & (K Units)

Table 64. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021e) & (USD Million)

Table 65. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2021-2026) & (USD Million)

Table 66. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 67. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 68. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 69. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 70. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021e) & (K Units)

Table 71. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2021-2026) & (K Units)

Table 72. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021e) & (USD Million)

Table 73. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2021-2026) & (USD Million)

Table 74. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 75. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 76. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 77. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 78. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021e) & (K Units)

Table 79. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2021-2026) & (K Units)

Table 80. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021e) & (USD Million)

Table 81. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2021-2026) & (USD Million)

Table 82. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 83. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 84. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 85. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 86. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021e) & (K Units)

Table 87. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2021-2026) & (K Units)

Table 88. South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021e) & (USD Million)

Table 89. South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2021-2026) & (USD Million)

Table 90. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 91. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 92. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 93. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 94. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021e) & (K Units)

Table 95. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2021-2026) & (K Units)

Table 96. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021e) & (USD Million)

Table 97. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2021-2026) & (USD Million)

Table 98. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021e) & (K Units)

Table 99. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2021-2026) & (K Units)

Table 100. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021e) & (K Units)

Table 101. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2021-2026) & (K Units)

Table 102. Direct Channel Pros & Cons

Table 103. Indirect Channel Pros & Cons

Table 104. Human Immunoglobulin(pH4) for Intravenous Injection Typical Distributors

Table 105. Human Immunoglobulin(pH4) for Intravenous Injection Typical Customers

List of Figures

Figure 1. Human Immunoglobulin(pH4) for Intravenous Injection Picture

Figure 2. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type in 2020

Figure 3. 1g/20ml

Figure 4. 1.25g/25ml

Figure 5. 2.5g/50ml

Figure 6. 5g/100ml

Figure 7. 10g/200ml

Figure 8. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application in 2020

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 13. Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size and Forecast (2016-2026) & (USD Million)

Figure 14. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales (2016-2026) & (K Units)

Figure 15. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2026) & (US$/Unit)

Figure 16. Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity (2016-2026) & (K Units)

Figure 17. Global Human Immunoglobulin(pH4) for Intravenous Injection Production Capacity by Geographic Region: 2020 VS 2021

Figure 18. Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers

Figure 19. Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints

Figure 20. Human Immunoglobulin(pH4) for Intravenous Injection Market Trends

Figure 21. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Manufacturer in 2020

Figure 22. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Manufacturer in 2020

Figure 23. Human Immunoglobulin(pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. Top 3 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturer (Revenue) Market Share in 2020

Figure 25. Top 6 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturer (Revenue) Market Share in 2020

Figure 26. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region (2016-2026)

Figure 27. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region (2016-2026)

Figure 28. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026) & (USD Million)

Figure 29. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026) & (USD Million)

Figure 30. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026) & (USD Million)

Figure 31. South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026) & (USD Million)

Figure 32. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue (2016-2026) & (USD Million)

Figure 33. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2026)

Figure 34. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type (2016-2026)

Figure 35. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2026) & (US$/Unit)

Figure 36. Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 37. Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application (2016-2026)

Figure 38. Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2026) & (US$/Unit)

Figure 39. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2026)

Figure 40. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 41. North America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2026)

Figure 42. North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2026)

Figure 43. United States Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Canada Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Mexico Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2026)

Figure 47. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 48. Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2026)

Figure 49. Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2026)

Figure 50. Germany Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. France Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. United Kingdom Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Russia Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Italy Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 57. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Region (2016-2026)

Figure 58. Asia-Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Region (2016-2026)

Figure 59. China Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Korea Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2026)

Figure 66. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 67. South America Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2026)

Figure 68. South America Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2026)

Figure 72. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2026)

Figure 73. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Country (2016-2026)

Figure 74. Middle East & Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Egypt Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Sales Channel: Direct Channel vs Indirect Channel

Figure 80. Methodology

Figure 81. Research Process and Data Source